Zobrazeno 1 - 10
of 56
pro vyhledávání: ''
Publikováno v:
The International Journal of Biological Markers. 36:14-22
Purpose Serum bilirubin plays an important role in antioxidant and anticancer processes. The inverse association between serum bilirubin and cancer risk have been widely reported in multiple cancers. The aim of this retrospective study was to investi
Publikováno v:
The International Journal of Biological Markers. 34:318-321
Objective:The aim of this study is to investigate the effect of colchicine and other medications for gout treatment on serum CA72-4 and other tumor markers including alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), CA19-9, CYFRA21-1, neuron s
Publikováno v:
The International Journal of Biological Markers. 34:381-388
Background: Non-small cell lung cancer (NSCLC) is difficult to treat when metastasis has occurred. This study explores the use of cell-free DNA in the clinical management of NSCLC patients who have Kirsten rat sarcoma viral oncogene homolog (KRAS)-po
Publikováno v:
The International Journal of Biological Markers. 34:168-175
Purpose:Numerous studies have suggested that dyslipidemia is closely related to various cancers and the high-density lipoprotein cholesterol (HDL-C) levels are associated with the outcome of cancer patients. However, the predictive value of HDL-C in
Autor:
Paola Gazzaniga, Federica Francescangeli, Cristina Raimondi, Simona Ceccarelli, Valentina Magri, Ann Zeuner, Patrizia Trenta, Cinzia Marchese, Chiara Nicolazzo, Angela Gradilone
Publikováno v:
The International Journal of Biological Markers. 32:415-420
Background Several studies have raised the issue of the inadequacy of CellSearch® to detect the entire pool of circulating tumor cells (CTCs) from blood of cancer patients, suggesting that cells expressing low levels of epithelial cell adhesion mole
Publikováno v:
The International Journal of Biological Markers. 32:434-440
Background Transrenal DNA can potentially be useful in the disease management of colorectal cancer (CRC) and has potential diagnostic utility. Our study aimed to conduct preoperative and postoperative analysis of KRAS-positive patients, using transre
Autor:
Gernot Kriegshäuser, Michael Oberwalder, Dietmar Enko, Hannes M. Müller, Matthias Zitt, Dietmar Öfner, Christian Oberkanins, Robert Zeillinger
Publikováno v:
The International Journal of Biological Markers. 32:467-470
Background This study aimed to evaluate the diagnostic performance of a novel nonquantitative methylation-specific reverse hybridization (MSRH) assay to detect secreted frizzled-related protein 2 ( SFRP2) promotor methylation in fecal DNA. Methods SF
Autor:
Lorena Rossi, Cecilia Menna, Salvatore Luca Burgio, Samanta Salvi, Wainer Zoli, Vincenza Conteduca, Matteo Costantini, Ugo De Giorgi, Valentina Casadio, Elisa Carretta
Publikováno v:
The International Journal of Biological Markers. 31:264-269
Background We evaluated the role of single nucleotide polymorphisms in the CYP17A1 gene for predicting clinical outcome in castration-resistant prostate cancer (CRPC) patients treated with abiraterone. Methods Sixty-four patients were genotyped for t
Publikováno v:
The International journal of biological markers. 33(2)
Purpose: Bone metastases from non-small cell lung cancer (NSCLC) are common, and current prognostic stratification methods are challenging to predict outcomes. The aim of the study is to examine circulating tumor DNA as a potential biomarker to gauge
Publikováno v:
The International Journal of Biological Markers. 30:200-207
Purpose This study aimed to evaluate the associations between metabolic syndrome (MS) and its components at initial diagnosis and outcomes of breast cancer including triple-negative breast cancer (TNBC) and non-TNBC. Methods A cohort of 1,391 patient